Drug Profile


Alternative Names: Aurograb

Latest Information Update: 02 Sep 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NeuTec Pharma
  • Class Antibacterials; Monoclonal antibodies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Methicillin-resistant Staphylococcus aureus infections

Most Recent Events

  • 29 Aug 2008 Discontinued - Phase-II for Meticillin-resistant Staphylococcus aureus infections in European Union (IV)
  • 14 Jul 2006 NeuTec Pharma has been acquired by Novartis
  • 16 Jun 2006 NeuTec Pharma has completed a phase III trial for Meticillin-resistant Staphylococcus aureus in Europe
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top